FMT, or fecal microbiota transplantation, could be the therapeutic solution for patients with Crohn’s disease or ulcerative colitis. But what exactly is this treatment, and how is it changing the treatment landscape for patients with inflammatory bowel disease? Dr. Stacy Kahn, from Boston Children’s Hospital, is joined by Dr. Jessica Allegretti, from Brigham & Women’s Hospital, to discuss this new treatment option for IBD patients.